Envoy Medical Statistics
Total Valuation
Envoy Medical has a market cap or net worth of $30.92 million. The enterprise value is $50.28 million.
Important Dates
The last earnings date was Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Envoy Medical has 21.33 million shares outstanding. The number of shares has increased by 35.09% in one year.
| Current Share Class | 21.33M |
| Shares Outstanding | 21.33M |
| Shares Change (YoY) | +35.09% |
| Shares Change (QoQ) | +30.48% |
| Owned by Insiders (%) | 38.07% |
| Owned by Institutions (%) | 15.22% |
| Float | 10.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 135.94 |
| Forward PS | 127.17 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 237.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.09
| Current Ratio | 1.09 |
| Quick Ratio | 0.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -129.07% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -698.17% |
| Revenue Per Employee | $5,048 |
| Profits Per Employee | -$632,714 |
| Employee Count | 42 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.49% in the last 52 weeks. The beta is 2.27, so Envoy Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.27 |
| 52-Week Price Change | -44.49% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 1.95 |
| Relative Strength Index (RSI) | 45.34 |
| Average Volume (20 Days) | 29,888 |
Short Selling Information
The latest short interest is 70,724, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 70,724 |
| Short Previous Month | 84,842 |
| Short % of Shares Out | 0.33% |
| Short % of Float | 0.66% |
| Short Ratio (days to cover) | 3.44 |
Income Statement
In the last 12 months, Envoy Medical had revenue of $212,000 and -$26.57 million in losses. Loss per share was -$1.36.
| Revenue | 212,000 |
| Gross Profit | -603,000 |
| Operating Income | -19.48M |
| Pretax Income | -23.04M |
| Net Income | -26.57M |
| EBITDA | -19.28M |
| EBIT | -19.48M |
| Loss Per Share | -$1.36 |
Full Income StatementBalance Sheet
The company has $5.31 million in cash and $24.03 million in debt, giving a net cash position of -$18.72 million or -$0.88 per share.
| Cash & Cash Equivalents | 5.31M |
| Total Debt | 24.03M |
| Net Cash | -18.72M |
| Net Cash Per Share | -$0.88 |
| Equity (Book Value) | -24.22M |
| Book Value Per Share | -1.14 |
| Working Capital | 717,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.09 million and capital expenditures -$877,000, giving a free cash flow of -$16.96 million.
| Operating Cash Flow | -16.09M |
| Capital Expenditures | -877,000 |
| Free Cash Flow | -16.96M |
| FCF Per Share | -$0.80 |
Full Cash Flow StatementMargins
| Gross Margin | -284.43% |
| Operating Margin | -9,188.21% |
| Pretax Margin | -9,208.96% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Envoy Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.09% |
| Shareholder Yield | -35.09% |
| Earnings Yield | -84.19% |
| FCF Yield | -53.74% |
Analyst Forecast
The average price target for Envoy Medical is $9.25, which is 537.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.25 |
| Price Target Difference | 537.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Envoy Medical has an Altman Z-Score of -44.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -44.44 |
| Piotroski F-Score | 1 |